Lyell Immunopharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lyell Immunopharma, Inc.
CIK #0001806952
EDGAR Form CIK 2011 - 2025
10-K [0001806952]
10-Q [0001806952]
3 [0001806952]
4 [0001806952]
8-K [0001806952]
D [0001806952]
SC 13G [0001806952]
Form 13D/13G Filer Form 13D/13G Subject Filed
Explore Investments Llc/De Lyell Immunopharma Inc [2025-08-19]
Gates Frontier LLC Lyell Immunopharma Inc [2025-08-01]
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2024-10-31]
BlackRock Inc Lyell Immunopharma Inc [2024-01-29]
Vanguard Group Inc Lyell Immunopharma Inc [2023-02-09]
MWG Management Ltd Lyell Immunopharma Inc [2022-02-14]
Arch Venture Fund IX LP Lyell Immunopharma Inc [2022-02-14]
Newton PTC Ltd Lyell Immunopharma Inc [2022-02-14]
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2022-02-11]
GlaxoSmithKline PLC Lyell Immunopharma Inc [2022-02-10]
Form 3/4/5 Subject 2011 - 2025
Lyell Immunopharma, Inc.
Newton Charles W.
Seely Lynn
Hill Stephen J.
Lee Gary K.
Crandell Keith
Gillis Steven
ARCH Venture Partners XIII, LLC
Berns Paul L
Nelsen Robert
ARCH Venture Partners XIII, L.P.
ARCH Venture Fund XIII, L.P.
Burow Kristina
ARCH Venture Partners IX Overage, L.P.
ARCH Venture Partners IX, L.P.
ARCH Venture Fund IX, L.P.
ARCH Venture Partners IX, LLC
Bybee Clinton
ARCH Venture Fund IX Overage, L.P.
Meltz Mark A
Bachleda Mark
Shook David
Nabel Elizabeth G
Klausner Richard
Rieflin William JL
Friedman Cathy
Brawley Otis W
Ramachandra Sumant
Lang Matthew
Bishop Hans Edgar
Albertson Tina M.
Thompson Rahsaan
Turner Heather D
Homans Elizabeth
GSK plc
Terms | Privacy | Guide
tony@aum13f.com